Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P
AUTOR(ES)
Dizon, Don S.
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2716935Documentos Relacionados
- A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
- Second-line agents in the treatment of rheumatic diseases
- Does second-line therapy affect the radiological progression of rheumatoid arthritis?
- Does second-line therapy affect the radiological progression of rheumatoid arthritis?
- Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial.